The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update
- PMID:14709771
- DOI: 10.1177/153537020422900101
The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update
Abstract
Colony stimulating factor (CSF-1) and its receptor (CSF-1R, product of c-fms proto-oncogene) were initially implicated as essential for normal monocyte development as well as for trophoblastic implantation. However, studies have demonstrated that CSF-1 and CSF-1R have additional roles in mammary gland development during pregnancy and lactation. This apparent role for CSF-1/CSF-1R in normal mammary gland development is very intriguing because this receptor/ligand pair has also been found to be important in the biology of breast cancer in which abnormal expression of CSF-1 and its receptor correlates with tumor cell invasiveness and adverse clinical prognosis. Recent findings also implicate tumor-produced CSF-1 in promotion of bone metastasis in breast cancer, and a certain membrane-associated form of CSF-1 appears to induce immunity against tumors. This review aims to summarize recent findings on the role of CSF-1 and its receptor in normal and neoplastic mammary development that may elucidate potential relationships of growth factor-induced biological changes in the breast during pregnancy and tumor progression.
Similar articles
- The role of CSF-1 in normal and neoplastic breast physiology.Sapi E, Kacinski BM.Sapi E, et al.Proc Soc Exp Biol Med. 1999 Jan;220(1):1-8. doi: 10.1046/j.1525-1373.1999.d01-1.x.Proc Soc Exp Biol Med. 1999.PMID:9893162Review.
- Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells.Sapi E, Flick MB, Rodov S, Carter D, Kacinski BM.Sapi E, et al.J Soc Gynecol Investig. 1998 Mar-Apr;5(2):94-101. doi: 10.1016/S1071-5576(97)00108-1.J Soc Gynecol Investig. 1998.PMID:9509388
- CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract.Kacinski BM.Kacinski BM.Mol Reprod Dev. 1997 Jan;46(1):71-4. doi: 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6.Mol Reprod Dev. 1997.PMID:8981366Review.
- Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.Kirma N, Luthra R, Jones J, Liu YG, Nair HB, Mandava U, Tekmal RR.Kirma N, et al.Cancer Res. 2004 Jun 15;64(12):4162-70. doi: 10.1158/0008-5472.CAN-03-2971.Cancer Res. 2004.PMID:15205327
- The macrophage growth factor CSF-1 in mammary gland development and tumor progression.Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW.Lin EY, et al.J Mammary Gland Biol Neoplasia. 2002 Apr;7(2):147-62. doi: 10.1023/a:1020399802795.J Mammary Gland Biol Neoplasia. 2002.PMID:12465600Review.
Cited by
- The ubiquitin ligases Cbl and Cbl-b regulate macrophage growth by controlling CSF-1R import into macropinosomes.Huang L, Thiex NW, Lou J, Ahmad G, An W, Low-Nam ST, Kerkvliet JG, Band H, Hoppe AD.Huang L, et al.Mol Biol Cell. 2024 Mar 1;35(3):ar38. doi: 10.1091/mbc.E23-09-0345. Epub 2024 Jan 3.Mol Biol Cell. 2024.PMID:38170572Free PMC article.
- IL-12 could induce monocytic tumor cells directional differentiation.Ma TT, Wu BT, Lin Y, Xiong HY, Wang Q, Li ZW, Cheng F, Tu ZG.Ma TT, et al.Mol Cell Biochem. 2015 Apr;402(1-2):157-69. doi: 10.1007/s11010-014-2323-9. Epub 2015 Jan 7.Mol Cell Biochem. 2015.PMID:25563480
- Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.Xu BJ, Yan W, Jovanovic B, An AQ, Cheng N, Aakre ME, Yi Y, Eng J, Link AJ, Moses HL.Xu BJ, et al.Proteomics. 2010 Jul;10(13):2458-70. doi: 10.1002/pmic.200900701.Proteomics. 2010.PMID:20405477Free PMC article.
- Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer.Nakhjavani M, Hardingham JE, Palethorpe HM, Price TJ, Townsend AR.Nakhjavani M, et al.J Breast Cancer. 2019 Sep;22(3):341-361. doi: 10.4048/jbc.2019.22.e39.J Breast Cancer. 2019.PMID:31598336Free PMC article.Review.
- Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer.Theou-Anton N, Faivre S, Dreyer C, Raymond E.Theou-Anton N, et al.Drug Saf. 2009;32(9):717-34. doi: 10.2165/00002018-200932090-00003.Drug Saf. 2009.PMID:19670913Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous